Alector, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Alector, Inc. (ALEC) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $153.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $153.20M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $185.60M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $214.40M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $265.20M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2026-06-30 | $153.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $185.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $214.40M 10-K · filed 2026-02-25 |
| 2025-09-30 | $265.20M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $278.80M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $334.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $364.80M 10-K · filed 2025-02-26 |
| 2024-09-30 | $398.10M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $426.60M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $476.60M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $503.10M 10-K · filed 2024-02-27 |
| 2023-09-30 | $550.50M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $563.30M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $565.10M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $640.80M 10-K · filed 2023-02-28 |
| 2022-09-30 | $671.30M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $683.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $649.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $488.20M 10-K · filed 2022-02-24 |
| 2021-09-30 | $332.40M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $261.00M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $286.90M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $336.90M 10-K · filed 2021-02-25 |
| 2020-09-30 | $359.30M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $424.70M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $486.30M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $311.80M 10-K · filed 2020-03-24 |
| 2019-09-30 | $349.30M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |